Phreesia Stock Price, News & Analysis

Phreesia has joined MEDITECH Greenfield, a pilot program aimed at fostering app integration with MEDITECH Expanse. This collaboration will enhance patient engagement in their care by enabling API-based integration, notifying patients about preventive care gaps, and reducing barriers to access. CEO Chaim Indig emphasized the importance of interoperability in healthcare, stating this partnership will support the development of innovative solutions for MEDITECH clients. The initiative aims to set an industry standard for interoperability.

Phreesia, listed on NYSE as PHR, has received recognition from PM360, a healthcare marketing publication, for its PatientInsights platform, which was named one of the 2021 Most Innovative Services. This honor reflects PatientInsights' effectiveness in conducting targeted patient surveys before doctor appointments, yielding higher completion rates and reliable data. The platform's integration with electronic health records streamlines survey processes, significantly reducing question counts. Phreesia continues to position itself at the forefront of patient-centric healthcare solutions.

Phreesia has been recognized by Medical Marketing and Media (MM+M) as one of the Best Places to Work 2021 in the healthcare marketing industry. This marks the fourth year of the awards, where Phreesia was highlighted in the 'Large Companies/Service Providers' category, being one of only two companies to receive this honor. Employees praised the company's inclusive culture and benefits, especially its response to COVID-19, which included enhanced pay and support for remote work. The recognition underscores Phreesia's commitment to transforming the patient experience.

Phreesia has acquired Insignia Health, LLC, a company focused on improving health outcomes through patient activation. This acquisition enhances Phreesia's mission to empower patients in their healthcare journey. Insignia holds the exclusive license for the Patient Activation Measure® (PAM®), recognized as the gold standard for assessing patient activation. The integration is expected to broaden PAM's reach, improving patient engagement and outcomes. Phreesia aims to leverage Insignia's expertise to provide more personalized care.

Phreesia, Inc. (NYSE: PHR) reported a strong fiscal third quarter ended October 31, 2021, with revenue reaching $55.9 million, a 45% increase year-over-year. The average number of provider clients grew by 21% to 2,097, with average revenue per client increasing by 10% to $19,299. Despite these positive metrics, the adjusted EBITDA was negative $17.6 million, reflecting increased investment. The company raised its revenue outlook for FY 2022 to $211 million and expects further growth of 20-25% in FY 2023.

Phreesia (NYSE: PHR) will host a conference call on December 9, 2021, at 8:45 a.m. ET to discuss its fiscal third quarter 2022 financial results. The financial results will be announced following market close on December 8, 2021. Phreesia provides healthcare organizations with a comprehensive suite of applications designed to improve the patient intake process, enhancing patient engagement and operational efficiency.

Phreesia has announced that General Counsel Allison Hoffman has been recognized in The Software Report’s list of the Top 50 Women Leaders in SaaS of 2021. This marks the fourth consecutive year that a Phreesia leader has achieved this honor. Hoffman, with over 25 years of legal expertise, joined Phreesia in 2020, overseeing the Legal, Compliance, Risk, Privacy, and Security teams. Her role also includes sponsoring the Phreesia Women’s Network. The Software Report emphasized the impact of women in executive positions in driving organizational success during the COVID-19 era.

Seminal Capital Holdings announces key appointments to its Seminal Healthcare team, including Victor Kats, Mark Miller, and Lindsey Watson. These professionals bring extensive experience in healthcare technology and investment. Kats, with over 25 years in the industry, previously led the Healthcare Technology Practice at Ascension Ventures. Miller and Watson also come with a wealth of expertise from notable firms. Seminal Healthcare aims to enhance its impact investing focus and provide strategic support to healthcare companies.